The Global Haemophilia Market Size Was Valued at USD 13.00 Billion in 2023 and is Projected to Reach USD 18.91 Billion by 2032, Growing at a CAGR of 4.25% From 2024-2032. Haemophilia is a rare genetic bleeding disorder characterized by the deficiency or absence of specific clotting factors, primarily Factor VIII (Haemophilia A) or Factor IX (Haemophilia B). This condition prevents the blood...